Flagship Ventures Fund V General Partner Llc

Affiliations

  • Large Shareholder at Sana Biotechnology Inc. (SANA), 2023-09-15
  • Large Shareholder at Sigilon Therapeutics Inc. (SGTX), 2023-08-15
  • Large Shareholder at Codiak Biosciences Inc. (CDAK), 2022-09-16
  • Large Shareholder at Omega Therapeutics Inc. (OMGA), 2021-08-05
  • Large Shareholder at Rubius Therapeutics Inc. (RUBY), 2021-03-23
  • Large Shareholder at Foghorn Therapeutics Inc. (FHTX), 2020-10-29
  • Large Shareholder, Director at Kaleido Biosciences Inc. (KLDO), 2019-03-06
  • Large Shareholder at Evelo Biosciences Inc. (EVLO), 2018-05-16
  • Large Shareholder at Denali Therapeutics Inc. (DNLI), 2017-12-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CDAK $0.00 210,743 Large Shareholder 1,188,920 2022-09-15 Filing
CDAK $0.00 722,590 Large Shareholder 1,865,767 2022-09-15 Filing
FHTX $16.00 50,000 Large Shareholder 1,851,801 2020-10-27 Filing
FHTX $16.00 50,000 Large Shareholder 1,491,441 2020-10-27 Filing
FHTX $16.00 50,000 Large Shareholder 9,330,878 2020-10-27 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SANA $6.24 22,760 Large Shareholder 1,380,277 2023-06-07 Filing
SANA $6.24 177,240 Large Shareholder 10,743,293 2023-06-07 Filing
SANA $6.31 22,297 Large Shareholder 1,403,037 2023-06-06 Filing
SANA $6.31 181,461 Large Shareholder 10,920,533 2023-06-06 Filing
SANA $6.23 9,330 Large Shareholder 1,425,334 2023-05-26 Filing